AlphaYouAG
Insider selling
Alastair Garfield sold $913K of Rhythm Pharmaceuticals, Inc. (RYTM) stock
Alastair Garfield, Chief Scientific Officer of Rhythm Pharmaceuticals, Inc. (RYTM), sold 7,763 shares of RYTM stock worth $913K, per an SEC Form 4 filed Aug 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 13, 2026, 4 days before it was made public.
RYTM has moved -14.8% since the trade date, from $116.02 to $98.83 (Sep 21, 2026 close).
- Traded
- Aug 13, 2026
- Disclosed
- Aug 17, 2026
- Filing delay
- 4 days
- Price since
- -14.8%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More RYTM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.